UBS Group’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.3M | Buy |
371,984
+133,768
| +56% | +$3.56M | ﹤0.01% | 3200 |
|
|
2025
Q4 | $6.87M | Buy |
238,216
+113,499
| +91% | +$1.48M | ﹤0.01% | 3702 |
|
|
2025
Q3 | $899K | Sell |
124,717
-424,710
| -77% | -$3.13M | ﹤0.01% | 5665 |
|
|
2025
Q2 | $5.46M | Buy |
549,427
+156,084
| +40% | +$1.65M | ﹤0.01% | 3786 |
|
|
2025
Q1 | $3.73M | Buy |
393,343
+270,525
| +220% | +$3.76M | ﹤0.01% | 4079 |
|
|
2024
Q4 | $1.69M | Buy |
122,818
+109,700
| +836% | +$1.92M | ﹤0.01% | 4888 |
|
|
2024
Q3 | $200K | Buy |
13,118
+4,431
| +51% | +$21.9K | ﹤0.01% | 5874 |
|
|
2024
Q2 | $41.4K | Buy |
8,687
+7,187
| +479% | +$40.1K | ﹤0.01% | 6837 |
|
|
2024
Q1 | $10.2K | Buy |
+1,500
| New | +$7.25K | ﹤0.01% | 7243 |
|
|
2023
Q2 | – | Sell |
-4,439
| Closed | -$18.7K | – | 8972 |
|
|
2023
Q1 | $18.7K | Buy |
+4,439
| New | +$19.1K | ﹤0.01% | 7134 |
|
|
2022
Q3 | – | Sell |
-29,352
| Closed | -$102K | – | 10363 |
|
|
2022
Q2 | $102K | Buy |
29,352
+22,462
| +326% | +$79.7K | ﹤0.01% | 5418 |
|
|
2022
Q1 | $23K | Buy |
6,890
+3,142
| +84% | +$12.4K | ﹤0.01% | 7282 |
|
|
2021
Q4 | $11K | Buy |
+3,748
| New | +$13.1K | ﹤0.01% | 8661 |
|
|
2021
Q3 | – | Sell |
-1,922
| Closed | -$10K | – | 9569 |
|
|
2021
Q2 | $10K | Buy |
1,922
+1,547
| +413% | +$6.55K | ﹤0.01% | 8028 |
|
|
2021
Q1 | $2K | Sell |
375
-4,701
| -93% | -$27.1K | ﹤0.01% | 8599 |
|
|
2020
Q4 | $17K | Buy |
5,076
+3,176
| +167% | +$13.8K | ﹤0.01% | 7051 |
|
|
2020
Q3 | $10K | Buy |
1,900
+900
| +90% | +$5.25K | ﹤0.01% | 6837 |
|
|
2020
Q2 | $5K | Sell |
1,000
-439
| -31% | -$1.91K | ﹤0.01% | 7362 |
|
|
2020
Q1 | $2K | Sell |
1,439
-3,974
| -73% | -$5.55K | ﹤0.01% | 7598 |
|
|
2019
Q4 | $7K | Buy |
5,413
+5,159
| +2,031% | +$10.6K | ﹤0.01% | 7437 |
|
|
2019
Q3 | $1K | Buy |
+254
| New | +$879 | ﹤0.01% | 7815 |
|
|
2019
Q2 | – | Sell |
-3,370
| Closed | -$16K | – | 7869 |
|
|
2019
Q1 | $16K | Buy |
3,370
+1,976
| +142% | +$10.2K | ﹤0.01% | 6477 |
|
|
2018
Q4 | $6K | Buy |
1,394
+1,323
| +1,863% | +$10.5K | ﹤0.01% | 7467 |
|
|
2018
Q3 | $1K | Sell |
71
-55
| -44% | -$655 | ﹤0.01% | 7819 |
|
|
2018
Q2 | $2K | Buy |
126
+86
| +215% | +$1.17K | ﹤0.01% | 7718 |
|
|
2018
Q1 | $1K | Sell |
40
-398
| -91% | -$6.91K | ﹤0.01% | 7624 |
|
|
2017
Q4 | $7K | Buy |
+438
| New | +$9.48K | ﹤0.01% | 7215 |
|
|
2017
Q2 | – | Sell |
-258
| Closed | -$9K | – | 7686 |
|
|
2017
Q1 | $9K | Buy |
258
+232
| +892% | +$6.44K | ﹤0.01% | 6664 |
|
|
2016
Q4 | $1K | Buy |
+26
| New | +$778 | ﹤0.01% | 7605 |
|
|
2016
Q3 | – | Sell |
-300
| Closed | -$12K | – | 7678 |
|
|
2016
Q2 | $12K | Buy |
+300
| New | +$10.6K | ﹤0.01% | 6668 |
|
|
2015
Q4 | – | Sell |
-278
| Closed | -$11K | – | 8349 |
|
|
2015
Q3 | $11K | Buy |
278
+131
| +89% | +$5.83K | ﹤0.01% | 7193 |
|
|
2015
Q2 | $7K | Sell |
147
-53
| -27% | -$3.33K | ﹤0.01% | 7678 |
|
|
2015
Q1 | $17K | Buy |
+200
| New | +$17.3K | ﹤0.01% | 7134 |
|
Other funds holding CAPR
SCM
TCM
VCM
RCM
JHC
